COVID-19 in children: clinical and epidemiological spectrum in the community.

Autor: García-Vera C; Primary Health Care Center 'José Ramón Muñoz Fernández', Zaragoza, Spain. cgarciavera@gmail.com., Castejón-Ramírez S; Hospital Materno-Infantil Miguel Servet, Zaragoza, Spain., Laín Miranda E; Public Health Technician in the Health Region II of Zaragoza, Zaragoza, Spain., Hernández Abadía R; Hospital Materno-Infantil Miguel Servet, Zaragoza, Spain., García Ventura M; Primary Health Care Center 'Valdespartera', Zaragoza, Spain., Borque Navarro E; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Rubio Sánchez P; Hospital Materno-Infantil Miguel Servet, Zaragoza, Spain., Baeta Ruiz Á; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Mengual Gil JM; Primary Health Care Center 'Delicias Sur', Zaragoza, Spain.
Jazyk: angličtina
Zdroj: European journal of pediatrics [Eur J Pediatr] 2022 Mar; Vol. 181 (3), pp. 1235-1242. Date of Electronic Publication: 2021 Aug 18.
DOI: 10.1007/s00431-021-04235-4
Abstrakt: Most publications on pediatric COVID-19 in Spain were performed at the beginning of the pandemic when some diagnostic tools were not widely available. This study aims to show the real spectrum of the infection based on wide detection of cases due to symptoms and contact tracing. A descriptive and analytical observational study was performed including pediatric cases (0 to 14 years) from the region of Aragón between May 12 and October 31, 2020. Diagnostics was by PCR detection of viral RNA, rapid antigen detection test, or positive IgG serology. There were 5933 positive children included. Of them, 49.03% were women. The mean age was 7.53 ± 4.28 years. The source of infection could not be determined in 17.8% of cases. As for the rest, was determined to be within the family environment in 67.8%. The percentage of asymptomatic patients was 50.3%. Among symptomatic patients, fever (58.1%) and cough (46.7%) were the most frequent symptoms. Hospitalization was required in 0.52% of infected, intensive care unit admission was on 0.05%, and there was one death (0.02%). Children under the age of one presented some symptoms more frequently (71.6% vs 48.5%; OR 2.68; 95% CI 2.08 to 3.45; p < 0.001) and required more hospitalizations (3.9% vs 0.34%; OR 11.52; 95% CI 5.65 to 23.52; p < 0.001).Conclusion: In our environment, SARS-CoV-2 infection is like other mild respiratory viral infections in the population under the age of 15. The contagion occurs mainly in the family environment, the number of asymptomatic is high, being the symptoms mild and the complications very infrequent. What is Known: • Pediatric infection produced by SARS-CoV-2 has manifested as a mild disease in relation to adult age, although with higher affectation at the youngest ages. • Nearly all studies on epidemiology and clinical spectrum of the disease were conducted with patients diagnosed at the beginning of the pandemic. By then, diagnostic tools were only available in hospitals and in emergency units. What is New: • Once diagnostic means were available in primary care medicine and were used not only for the diagnosis of clinical symptoms of the patient, but for the tracing of case contacts, a much more precise approach to the epidemiology and clinical manifestations of the disease was allowed, as described in this study.
(© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje